{
    "2020-07-23": [
        [
            {
                "time": "",
                "original_text": "核心资产有变：公募Q2扫货科技医药 最新重仓股曝光(名单)",
                "features": {
                    "keywords": [
                        "核心资产",
                        "公募基金",
                        "科技",
                        "医药",
                        "重仓股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "核心资产有变！公募基金二季度扫货科技医药，抛弃金融地产，最新重仓股曝光（附名单）",
                "features": {
                    "keywords": [
                        "核心资产",
                        "公募基金",
                        "科技",
                        "医药",
                        "金融",
                        "地产",
                        "重仓股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "医药",
                        "金融",
                        "地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "89只股股价创历史新高",
                "features": {
                    "keywords": [
                        "股价",
                        "历史新高"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "揭秘送转股304只除权以来股价上涨",
                "features": {
                    "keywords": [
                        "送转股",
                        "除权",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "第三批集采品种名单公布 关注重点品种竞争格局重构",
                "features": {
                    "keywords": [
                        "集采",
                        "品种名单",
                        "竞争格局"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中国医药工业百强系列榜单发布 高瓴投出CRO榜单前三甲",
                "features": {
                    "keywords": [
                        "医药工业",
                        "百强榜单",
                        "高瓴资本",
                        "CRO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中银创新医疗混合基金最新净值涨幅达1.93％",
                "features": {
                    "keywords": [
                        "中银创新医疗",
                        "混合基金",
                        "净值涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中银证券健康产业灵活配置混合基金最新净值涨幅达1.90％",
                "features": {
                    "keywords": [
                        "中银证券",
                        "健康产业",
                        "灵活配置",
                        "净值涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本包揽凯莱英定增生变，半年已扫货十余家生物医药公司",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "凯莱英",
                        "定增",
                        "生物医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[浙商医药|周报]持续关注Q2基金重仓提升的制药创新产业链─医药行业周报",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "基金重仓",
                        "制药创新",
                        "医药行业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}